Related Experiment Video
Updated: Mar 19, 2026

10:32
Transvaginal Mesh Insertion in the Ovine Model
Published on: July 27, 2017
17.1K
How to Avoid and Deal with Pelvic Mesh Litigation
1Division of Female Pelvic Health, Arizona State Urological Institute, 4530 E. Ray Rad, Suite 178, Phoenix, AZ, 85044, USA. karlovskym@yahoo.com.
Current Urology Reports
|June 12, 2016
Summary
Informed consent for transvaginal mesh surgery requires discussing risks, FDA classification, and physician experience. Thorough patient counseling and documentation are crucial to mitigate medical malpractice risks associated with mesh implantation.
Area of Science:
- Urology
- Gynecology
- Medical Law
Background:
- Transvaginal mesh implantation is a surgical option for stress urinary incontinence and pelvic organ prolapse.
- Medical malpractice claims are a concern in procedures involving transvaginal mesh.
Purpose of the Study:
- To outline the essential components of informed consent for transvaginal mesh procedures.
- To emphasize strategies for mitigating medical malpractice risks in mesh implantation surgeries.
Main Methods:
- Review of medical malpractice considerations in transvaginal mesh surgery.
- Analysis of informed consent requirements, risk assessment, and physician responsibilities.
Main Results:
- Informed consent must cover mesh specifics, FDA classification, off-label use, and conflicts of interest.
- Physician-patient therapeutic alliance, risk assessment, and meticulous documentation are vital.
Conclusions:
- Comprehensive patient education and documentation are key to managing patient expectations and reducing litigation risk.
- Skilled surgical practice, clear communication, and adherence to guidelines can avert mesh-related malpractice claims.

